Trump Backing for Bayer’s Monsanto Deal Buoys Investors

FRANKFURT—Investors in Bayer AG have taken heart from President Donald Trump’s apparent support for the German pharmaceuticals and chemicals firm’s planned $ 57 billion takeover of U.S. seed giant Monsanto Co. and are cautiously optimistic the deal will pass regulatory muster.

Bayer, which reports full-year results on Wednesday, seems to have put the deal on firmer ground by reassuring President Trump last month that it is committed to investing in the U.S. and maintaining American jobs, investors and analysts…

Let’s block ads! (Why?) US Business